Surrozen, Inc. (SRZN) short interest & options flow
NASDAQSurrozen reported Q1 2026 results after the close on May 6, delivering a headline EPS miss that would ordinarily send a clinical-stage biotech sharply lower — yet the setup heading into the print was notably bullish, and the stock had already moved hard in anticipation. The EPS miss is difficult to dismiss. Surrozen posted -$11.65 per share against a consensus estimate of -$1.09, a…
- Market cap
- $554M
- Next earnings
- 6 Nov 2026
Key data as of 5 Nov 2026

SRZN news and analysis
RSSNo long-form analysis yet for SRZN. Pulse alerts and the live data picture are available on ORTEX.
Open SRZN on ORTEX →Want the live picture for SRZN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SRZN — free to start on ORTEX.
Sign up for free →Open SRZN on ORTEX